Bellerophon Therapeutics, Inc. Analytics - Traffic, Statistics and Competitor Tracking


Bellerophon Therapeutics, Inc. Website Screenshot

http://www.bellerophon.com

Bellerophon Therapeutics, Inc. Company Intro

Bellerophon Therapeutics is a clinical-stage biotherapeutics company. We are focused on developing innovative therapies in the treatment of cardiopulmonary diseases. Our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need. More … Continued

Industry

Healthcare

Bellerophon Therapeutics, Inc. Headquaters

184 Liberty Corner Road
Warren,07059
United States


Bellerophon Therapeutics, Inc. Share price

14 May 2021 01:15 GMT

$4.0200

0.02 (0.5 %)


Bellerophon Therapeutics, Inc. Market cap

$37.836 M


WMC RANKING

2021

Bellerophon Therapeutics, Inc. # 455

Biotechnology

Latest Bellerophon Therapeutics, Inc. News

News 11 May 2021

Global Interstitial Lung Disease (ILD) Market Size, Share ...

The key manufacturers covered in this report: Breakdown data in in Chapter 3. Boehringer Ingelheim Bellerophon Therapeutics, Inc Fujirebio (Miraca) Philips

News 11 May 2021

Form 8-K Bellerophon Therapeutics For: May 11

Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative therapies that address significant unmet medical needs in ...

News 11 May 2021

Bellerophon Therapeutics Q1 Loss Per Share $0.58 - CMLViz ...

Bellerophon Therapeutics Inc (BLPH) - Bellerophon Provides Clinical ... As of March 31, 2021, Company Had Cash and Cash Equivalents of $39.7 Million.


WMC Market Score


WMC Market to Revenue Score


Bellerophon Therapeutics, Inc. Market Financials


Revenue, Expenses, Profit


Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Bellerophon Therapeutics, Inc. USD $0 $26,276 $-24,728 $378M 455
Regeneron Pharmaceuticals, Inc. USD $9,243,500 $5,152,600 $3,156,000 $540,220B 1
Vertex Pharmaceuticals Incorporated USD $6,205,683 $2,599,993 $2,711,647 $550,560B 2
Alexion Pharmaceuticals, Inc. USD $6,069,900 $2,656,500 $603,400 $380,130B 3
Incyte Corporation USD $2,229,409 $1,622,822 $446,906 $181,110B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Bellerophon Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors



Bellerophon Therapeutics, Inc. Post vs Top 4 Industry Competitors




Bellerophon Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors



Bellerophon Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors



Bellerophon Therapeutics, Inc. WMC Market Score Calculations


Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Bellerophon Therapeutics, Inc. 0 0 0 0 0 0 0.02
Regeneron Pharmaceuticals, Inc. 100 23.93 2.32 100 0 0 48.53
Vertex Pharmaceuticals Incorporated 67.14 34.98 0.73 86 0 0 46.73
Alexion Pharmaceuticals, Inc. 65.67 100 100 60 0 0 100
Incyte Corporation 24.12 4.93 0.05 2 0 0 2.85

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries